The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins.
Saved in:
| Title: | The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins. |
|---|---|
| Authors: | Biswas S; University Hospitals Southampton NHS Foundation Trust, Southampton General Hospital, Division of Medical Oncology, Sarcoma Unit , Floor D, East Wing, Southampton, Tremona Road, Southampton, SO16 6YD , UK swethajit.biswas@uhs.nhs.uk., Killick E, Jochemsen AG, Lunec J |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2014 May; Vol. 23 (5), pp. 629-45. Date of Electronic Publication: 2014 Feb 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-7658 |
|---|---|
| DOI: | 10.1517/13543784.2014.892924 |
